Scan Medical Insurance

Cinergy Health Insurance News

New data from Zafgen's ZGN-433 Phase 1b study on obesity presented at ADA 2011Sunday, June 26, 2011 @ 11:35PMZafgen, Inc., a pharmaceutical company pioneering novel obesity therapeutics to help the body regain and sustain a lean, healthy state by targeting imbalances in fat metabolism, today announced new data from a Phase 1b study of ZGN-433, a selective methionine aminopeptidase 2 inhibitor (MetAP2), which showed a significant improvement in cardiovascular risk markers in severely obese subjects.

Unigene first quarter net loss decreases 58% to $6.6 millionMonday, May 9, 2011 @ 11:05AMUnigene Laboratories, Inc. a leader in the design, delivery, manufacture and development of peptide-based therapeutics announced first quarter financial results for the period ended March 31, 2011. The Company highlighted significant progress achieved in the first quarter with the execution of its turnaround strategy.

Duke Energy Posts Solid First-Quarter 2011 ResultsTuesday, May 3, 2011 @ 6:00AM-

New findings may open doors for vaccine development against HIV, tuberculosisMonday, March 14, 2011 @ 11:41PMAlum is an adjuvant used in many common vaccines, and Canadian researchers have now discovered how it works. The research by scientists from the University of Calgary's Faculty of Medicine is published in the March 13 online edition of Nature Medicine.

Roundup: Mass. BCBS chief on health costs; Georgia insurance exchange, Arizona waiver requestMonday, January 24, 2011 @ 9:22AMArizona Gov. Jan Brewer has signed emergency legislation authorizing her to request a two-year waiver from the CMS to reduce Medicaid rolls by 280,000 people. Brewer said in a statement she intends to request the waiver as early as Monday. She added that she plans to meet with HHS Secretary Kathleen Sebelius in the coming weeks to discuss "the dire need for a Medicaid waiver for Arizona".

Esperion Therapeutics commences ETC-1002 Phase 2 clinical study for Cardio-metabolic diseasesFriday, January 7, 2011 @ 1:08AMEsperion Therapeutics, a privately held biotechnology company working to discover, develop and commercialize treatments for cardiovascular and metabolic diseases, today announced that it has initiated a Phase 2 clinical study for ETC-1002, the company's lead product candidate.

Health Care Under the Golden Arches: Cheap But FaultyFriday, December 3, 2010 @ 10:39AMThere's a central maxim to health insurance pricing: If it seems too good to be true, it is. Health insurance is basically standardized gambling. Insurers set premiums based on how much risk is posed by those who enroll in their … Continue reading →

Scott campaign buys newspaper ads to criticize SinkSaturday, October 16, 2010 @ 1:00PMNo Summary Available

Scott lambastes Sink's office for licensing felons to sell insuranceFriday, October 15, 2010 @ 8:01PMScott lambastes Sink's office for licensing felons to sell insurance